[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Telmisartan Market Report by Indication (Hypertension, Cardiovascular Risk Reduction), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Stores), and Region 2024-2032

August 2024 | 150 pages | ID: T3616CEFF815EN
IMARC Group

US$ 3,509.00 US$ 3,899.00 -10 %
Offer valid until December 31, 2024!

E-mail Delivery (PDF), Hard Copy Mail Delivery, CD-ROM Mail Delivery

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global telmisartan market size reached US$ 3.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.8 Billion by 2032, exhibiting a growth rate (CAGR) of 2.7% during 2024-2032.

Telmisartan is a non-peptide angiotensin receptor blocker (ARB), which is used as a prescription drug for the treatment of hypertension and cardiovascular disorders. It is commonly available in tablets and oral oil suspension variants and is administered with other medications to enhance its efficacy. It exhibits antihypertensive properties and inhibits aldosterone production in the body, thereby leading to a decrease in sodium and water absorption and subsequent reduction in the blood pressure. Telmisartan also relaxes the blood vessels and promotes kidney function. However, it may cause various side effects, such as dizziness, lightheadedness, cough and sinus pain.

Telmisartan Market Trends:

Significant growth in the pharmaceutical industry across the globe is one of the key factors creating a positive outlook for the market. Moreover, the increasing prevalence of high blood pressure, diabetes and various kidney-related disorders is providing a thrust to the market growth. Telmisartan has been proven effective in modifying genes for insulin sensitization and regulating glucose and lipid metabolism, which aids in managing chronic diabetic kidney disease and other disorders caused by sedentary lifestyles. Pharmaceutical manufacturers are also launching generic versions of telmisartan medications to provide cost-effective treatment to hypertension and cardiovascular ailments. Additionally, drug manufacturers are investing significantly in the research and development (R&D) of advanced telmisartan medications for the treatment of diabetic nephropathy, which is also contributing to the growth of the market. Other factors, including the rising geriatric population, along with significant improvements in the healthcare infrastructure, are anticipated to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global telmisartan market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on indication and distribution channel.

Breakup by Indication:
  • Hypertension
  • Cardiovascular Risk Reduction
Breakup by Distribution Channel:
  • Hospital Pharmacies
  • Drug Stores and Retail Pharmacies
  • Online Stores
Breakup by Region:
  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Aurobindo Pharma USA, Boehringer Ingelheim International GmbH, Cipla Limited, Hikma Pharmaceuticals plc, Jubilant Cadista Pharmaceutical, Sanofi S.A., Solco Healthcare (Prinston Pharmaceutical Inc.) and Torrent Pharmaceuticals Ltd.

Key Questions Answered in This Report:
  • How has the global telmisartan market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global telmisartan market?
  • What are the key regional markets?
  • What is the breakup of the market based on the indication?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global telmisartan market and who are the key players?
  • What is the degree of competition in the industry?
1 PREFACE

2 SCOPE AND METHODOLOGY

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
  2.3.1 Primary Sources
  2.3.2 Secondary Sources
2.4 Market Estimation
  2.4.1 Bottom-Up Approach
  2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 EXECUTIVE SUMMARY

4 INTRODUCTION

4.1 Overview
4.2 Key Industry Trends

5 GLOBAL TELMISARTAN MARKET

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 MARKET BREAKUP BY INDICATION

6.1 Hypertension
  6.1.1 Market Trends
  6.1.2 Market Forecast
6.2 Cardiovascular Risk Reduction
  6.2.1 Market Trends
  6.2.2 Market Forecast

7 MARKET BREAKUP BY DISTRIBUTION CHANNEL

7.1 Hospital Pharmacies
  7.1.1 Market Trends
  7.1.2 Market Forecast
7.2 Drug Stores and Retail Pharmacies
  7.2.1 Market Trends
  7.2.2 Market Forecast
7.3 Online Stores
  7.3.1 Market Trends
  7.3.2 Market Forecast

8 MARKET BREAKUP BY REGION

8.1 North America
  8.1.1 United States
    8.1.1.1 Market Trends
    8.1.1.2 Market Forecast
  8.1.2 Canada
    8.1.2.1 Market Trends
    8.1.2.2 Market Forecast
8.2 Asia-Pacific
  8.2.1 China
    8.2.1.1 Market Trends
    8.2.1.2 Market Forecast
  8.2.2 Japan
    8.2.2.1 Market Trends
    8.2.2.2 Market Forecast
  8.2.3 India
    8.2.3.1 Market Trends
    8.2.3.2 Market Forecast
  8.2.4 South Korea
    8.2.4.1 Market Trends
    8.2.4.2 Market Forecast
  8.2.5 Australia
    8.2.5.1 Market Trends
    8.2.5.2 Market Forecast
  8.2.6 Indonesia
    8.2.6.1 Market Trends
    8.2.6.2 Market Forecast
  8.2.7 Others
    8.2.7.1 Market Trends
    8.2.7.2 Market Forecast
8.3 Europe
  8.3.1 Germany
    8.3.1.1 Market Trends
    8.3.1.2 Market Forecast
  8.3.2 France
    8.3.2.1 Market Trends
    8.3.2.2 Market Forecast
  8.3.3 United Kingdom
    8.3.3.1 Market Trends
    8.3.3.2 Market Forecast
  8.3.4 Italy
    8.3.4.1 Market Trends
    8.3.4.2 Market Forecast
  8.3.5 Spain
    8.3.5.1 Market Trends
    8.3.5.2 Market Forecast
  8.3.6 Russia
    8.3.6.1 Market Trends
    8.3.6.2 Market Forecast
  8.3.7 Others
    8.3.7.1 Market Trends
    8.3.7.2 Market Forecast
8.4 Latin America
  8.4.1 Brazil
    8.4.1.1 Market Trends
    8.4.1.2 Market Forecast
  8.4.2 Mexico
    8.4.2.1 Market Trends
    8.4.2.2 Market Forecast
  8.4.3 Others
    8.4.3.1 Market Trends
    8.4.3.2 Market Forecast
8.5 Middle East and Africa
  8.5.1 Market Trends
  8.5.2 Market Breakup by Country
  8.5.3 Market Forecast

9 SWOT ANALYSIS

9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats

10 VALUE CHAIN ANALYSIS

11 PORTERS FIVE FORCES ANALYSIS

11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes

12 PRICE ANALYSIS

13 COMPETITIVE LANDSCAPE

13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
  13.3.1 Abbott Laboratories
    13.3.1.1 Company Overview
    13.3.1.2 Product Portfolio
    13.3.1.3 Financials
    13.3.1.4 SWOT Analysis
  13.3.2 Aurobindo Pharma USA
    13.3.2.1 Company Overview
    13.3.2.2 Product Portfolio
    13.3.2.3 Financials
  13.3.3 Boehringer Ingelheim International GmbH
    13.3.3.1 Company Overview
    13.3.3.2 Product Portfolio
  13.3.4 Cipla Limited
    13.3.4.1 Company Overview
    13.3.4.2 Product Portfolio
    13.3.4.3 Financials
    13.3.4.4 SWOT Analysis
  13.3.5 Hikma Pharmaceuticals plc
    13.3.5.1 Company Overview
    13.3.5.2 Product Portfolio
    13.3.5.3 Financials
    13.3.5.4 SWOT Analysis
  13.3.6 Jubilant Cadista Pharmaceutical
    13.3.6.1 Company Overview
    13.3.6.2 Product Portfolio
  13.3.7 Sanofi S.A.
    13.3.7.1 Company Overview
    13.3.7.2 Product Portfolio
    13.3.7.3 Financials
    13.3.7.4 SWOT Analysis
  13.3.8 Solco Healthcare (Prinston Pharmaceutical Inc.)
    13.3.8.1 Company Overview
    13.3.8.2 Product Portfolio
  13.3.9 Torrent Pharmaceuticals Ltd
    13.3.9.1 Company Overview
    13.3.9.2 Product Portfolio
    13.3.9.3 Financials
    13.3.9.4 SWOT Analysis

LIST OF TABLES

Table 1: Global: Telmisartan Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Telmisartan Market Forecast: Breakup by Indication (in Million US$), 2024-2032
Table 3: Global: Telmisartan Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 4: Global: Telmisartan Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 5: Global: Telmisartan Market: Competitive Structure
Table 6: Global: Telmisartan Market: Key Players

LIST OF FIGURES

Figure 1: Global: Telmisartan Market: Major Drivers and Challenges
Figure 2: Global: Telmisartan Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Telmisartan Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Telmisartan Market: Breakup by Indication (in %), 2023
Figure 5: Global: Telmisartan Market: Breakup by Distribution Channel (in %), 2023
Figure 6: Global: Telmisartan Market: Breakup by Region (in %), 2023
Figure 7: Global: Telmisartan (Hypertension) Market: Sales Value (in Million US$), 2018 & 2023
Figure 8: Global: Telmisartan (Hypertension) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 9: Global: Telmisartan (Cardiovascular Risk Reduction) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Telmisartan (Cardiovascular Risk Reduction) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Telmisartan (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Telmisartan (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Telmisartan (Drug Stores and Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Telmisartan (Drug Stores and Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Telmisartan (Online Stores) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Telmisartan (Online Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: North America: Telmisartan Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: North America: Telmisartan Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: United States: Telmisartan Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: United States: Telmisartan Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Canada: Telmisartan Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Canada: Telmisartan Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Asia-Pacific: Telmisartan Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Asia-Pacific: Telmisartan Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: China: Telmisartan Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: China: Telmisartan Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Japan: Telmisartan Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Japan: Telmisartan Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: India: Telmisartan Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: India: Telmisartan Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: South Korea: Telmisartan Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: South Korea: Telmisartan Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Australia: Telmisartan Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Australia: Telmisartan Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Indonesia: Telmisartan Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Indonesia: Telmisartan Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: Others: Telmisartan Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: Others: Telmisartan Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: Europe: Telmisartan Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: Europe: Telmisartan Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Germany: Telmisartan Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Germany: Telmisartan Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: France: Telmisartan Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: France: Telmisartan Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: United Kingdom: Telmisartan Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: United Kingdom: Telmisartan Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: Italy: Telmisartan Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: Italy: Telmisartan Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: Spain: Telmisartan Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: Spain: Telmisartan Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: Russia: Telmisartan Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: Russia: Telmisartan Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: Others: Telmisartan Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: Others: Telmisartan Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: Latin America: Telmisartan Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: Latin America: Telmisartan Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: Brazil: Telmisartan Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: Brazil: Telmisartan Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: Mexico: Telmisartan Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: Mexico: Telmisartan Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Others: Telmisartan Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Others: Telmisartan Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: Middle East and Africa: Telmisartan Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: Middle East and Africa: Telmisartan Market: Breakup by Country (in %), 2023
Figure 65: Middle East and Africa: Telmisartan Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Global: Telmisartan Industry: SWOT Analysis
Figure 67: Global: Telmisartan Industry: Value Chain Analysis
Figure 68: Global: Telmisartan Industry: Porter's Five Forces Analysis


More Publications